Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
US11732030B2 · kind B2 · utility
1Cited by
9References
51Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 2021 |
| Grant date | Aug 22, 2023 |
| Priority date | — |
| Expiry date | Jun 9, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.